DTaP and Tdap Vaccines Market Report 2024: History, Forecast, and Analysis from 2017 to 2030

    Factors such as high birth rate, increase in number of geriatric population, government initiatives, growth in adoption of pertussis vaccination, and government insurance and reimbursement scenario are projected to drive the pertussis vaccine market globally. According to WHO in 2015, 126 countries had reached at least 90% coverage of diphtheria-tetanus-pertussis vaccine. On the other hand, factors such as vaccine injuries and adverse event are expected to hinder the growth of the pertussis vaccine market globally. In the U.S. in 2015, there had been 7 claims filed in the federal Vaccine Injury Compensation Program (VICP) for injuries and deaths following pertussis vaccination, including three deaths and four serious injuries.

    The pertussis vaccine market has been segmented by product type, vaccine type, age group, end-user, and geography. In terms of product type, the pertussis vaccine market is classified into DTaP vaccine and Tdap vaccine. The DTaP vaccine segment includes products such as Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel. The Tdap vaccine segment comprises products such as Boostrix and Adacel. In terms of vaccine type, the pertussis vaccine market is classified into whole-cell vaccine and acellular vaccine. The acellular vaccine segment is highly used owing to less side effect. The acellular vaccine is about 71%–85% effective, whereas whole-cell vaccine is about 78% effective. In terms of age group, the pertussis vaccine market is classified into adult and pediatric. In terms of end-user, the market is classified into hospitals, clinics, and vaccination centers. Geographically, the pertussis vaccine market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

    North America dominates the pertussis vaccine market due to growth in number of geriatric population and increase in pertussis death rate in the U.S, which drive the pertussis vaccine market. In 2014, according to the CDC, 28,660 cases of pertussis were reported in the U.S. The North America market is followed by the Europe and Asia Pacific markets. Asia Pacific is expected to grow at a higher rate due to rapid population growth, increase in adoption for vaccination, and growth in prevalence of infectious disease. These factors are expected to fuel the pertussis vaccine market. In the Asia Pacific region, Thailand accounts for 99% in pertussis vaccine coverage, followed by Japan and China with 98% and 97%, respectively. Developing countries such as Brazil, South Africa, and Mexico are estimated to create good opportunity for the pertussis vaccine market growth attributing to rise in number of government and private health care insurance coverage, increase in health care expenditure, and growth in awareness among people.

    The global market for DTaP and Tdap Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

QYResearch (Global Market Report Research Publisher) announces the release of 2024 latest report “DTaP and Tdap Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030”. Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global DTaP and Tdap Vaccines market, including market size, share, demand, industry development status, and forecasts for the next few years.

This report will help you generate, evaluate and implement strategic decisions as it provides the necessary information on technology-strategy mapping and emerging trends. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】 

https://www.qyresearch.com/reports/2331225/dtap-and-tdap-vaccines

This DTaP and Tdap Vaccines Market Research/Analysis Report includes the following points:

• How much is the global DTaP and Tdap Vaccinesmarket worth? What was the value of the market In 2020?
• Would the market witness an increase or decline in the demand in the coming years?
• What is the estimated demand for different typesand upcoming industry applications of products in DTaP and Tdap Vaccines?
• What are Projections of Global DTaP and Tdap VaccinesIndustry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit?
• What Will Be Market Share, Supply,Consumption and Import and Export of DTaP and Tdap Vaccines? 
• What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for DTaP and Tdap VaccinesIndustry?
• Where will the strategic developments take the industry in the mid to long-term?
• What are the factors contributing to the final price of DTaP and Tdap Vaccines? What are the raw materials used for DTaP and Tdap Vaccinesmanufacturing?
• Who are the major Manufacturersin the DTaP and Tdap Vaccines market? Which companies are the front runners?
• Which are the recent industry trends that can be implemented to generate additional revenue streams?

The report provides a detailed analysis of the market size, growth potential, and key trends for each segment. Through detailed analysis, industry players can identify profit opportunities, develop strategies for specific customer segments, and allocate resources effectively.

The DTaP and Tdap Vaccines market is segmented as below:

By Company

    Sanofi Pasteur

    GlaxoSmithKline

    Protein Sciences Corporation

    Novartis AG

    Seqirus

    Merck Sharp & Dohme Corp

    Astellas Pharma US, Inc

    Pfizer Inc

    Johnson & Johnson

    Lanzhou Institute of Biological Products Co., Ltd

    AstraZeneca

    Emergent BioSolutions Inc

Segment by Type

    DTaP

    Td

    Tdap

Segment by Application

    Adult

    Pediatric

This information will help stakeholders make informed decisions and develop effective strategies for growth. The report's analysis of the restraints in the market is crucial for strategic planning as it helps stakeholders understand the challenges that could hinder growth. This information will enable stakeholders to devise effective strategies to overcome these challenges and capitalize on the opportunities presented by the growing market. Furthermore, the report incorporates the opinions of market experts to provide valuable insights into the market's dynamics. This information will help stakeholders gain a better understanding of the market and make informed decisions.

Each chapter of the report provides detailed information for readers to further understand the DTaP and Tdap Vaccines market:

Chapter One: Introduces the study scope of this report, executive summary of market segment by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Two: Detailed analysis of DTaP and Tdap Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Three: Sales, revenue of DTaP and Tdap Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter Four: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.

Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.

Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Analysis of sales channel, distributors and customers.

Chapter Thirteen: Research Findings and Conclusion.

Table of Contents

1 DTaP and Tdap Vaccines Market Overview

1.1 DTaP and Tdap Vaccines Product Overview

1.2 DTaP and Tdap Vaccines Market by Type

1.3 Global DTaP and Tdap Vaccines Market Size by Type

1.3.1 Global DTaP and Tdap Vaccines Market Size Overview by Type (2019-2030)

1.3.2 Global DTaP and Tdap Vaccines Historic Market Size Review by Type (2019-2024)

1.3.3 Global DTaP and Tdap Vaccines Forecasted Market Size by Type (2025-2030)

1.4 Key Regions Market Size by Type

1.4.1 North America DTaP and Tdap Vaccines Sales Breakdown by Type (2019-2024)

1.4.2 Europe DTaP and Tdap Vaccines Sales Breakdown by Type (2019-2024)

1.4.3 Asia-Pacific DTaP and Tdap Vaccines Sales Breakdown by Type (2019-2024)

1.4.4 Latin America DTaP and Tdap Vaccines Sales Breakdown by Type (2019-2024)

1.4.5 Middle East and Africa DTaP and Tdap Vaccines Sales Breakdown by Type (2019-2024)

2 DTaP and Tdap Vaccines Market Competition by Company

2.1 Global Top Players by DTaP and Tdap Vaccines Sales (2019-2024)

2.2 Global Top Players by DTaP and Tdap Vaccines Revenue (2019-2024)

2.3 Global Top Players by DTaP and Tdap Vaccines Price (2019-2024)

2.4 Global Top Manufacturers DTaP and Tdap Vaccines Manufacturing Base Distribution, Sales Area, Product Type

2.5 DTaP and Tdap Vaccines Market Competitive Situation and Trends

2.5.1 DTaP and Tdap Vaccines Market Concentration Rate (2019-2024)

2.5.2 Global 5 and 10 Largest Manufacturers by DTaP and Tdap Vaccines Sales and Revenue in 2023

2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTaP and Tdap Vaccines as of 2023)

2.7 Date of Key Manufacturers Enter into DTaP and Tdap Vaccines Market

2.8 Key Manufacturers DTaP and Tdap Vaccines Product Offered

2.9 Mergers & Acquisitions, Expansion

...

Overall, this report strives to provide you with the insights and information you need to make informed business decisions and stay ahead of the competition.

To contact us and get this report: https://www.qyresearch.com/contact-us

About Us：

QY Research (QYResearch) founded in California, USA in 2007, which is a leading global market research and consulting company. Our primary business include market research reports, custom reports, commissioned research, IPO consultancy, business plans, etc. With over 16 years of experience and a dedicated research team, QYResearch have offices in 7 countries - the United States, Japan, Korea, China, Germany, Switzerland and India - and partnerships with business partners in more than 30 countries around the world. To date, we have provided industry information services to more than 60,000 companies in over 160 countries.

Contact Us:

If you have any queries regarding this report or if you would like further information, please Contact us:

QY Research Inc. (QYResearch)

Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States

E-mail: global@qyresearch.com

Tel: 001-626-842-1666(US) 0086-133 1872 9947(CN)

EN: https://www.qyresearch.com

JP: https://www.qyresearch.co.jp